Intrinseque Health Announces Plans to Establish State-of-the-Art GMP-Certified Warehouse in Melaka, Malaysia.

April 29, 2025 12:29 AM PDT | By EIN Presswire
 Intrinseque Health Announces Plans to Establish State-of-the-Art GMP-Certified Warehouse in Melaka, Malaysia.
Image source: EIN Presswire

MELAKA, MALAYSIA, April 29, 2025 /EINPresswire.com/ -- As part of its continued commitment to enhancing the talent pool in Melaka and strengthening its service offerings, Intrinseque Health, a leading global clinical supply chain solutions provider, is proud to announce its plans to establish a new GMP-certified warehouse facility in Melaka, Malaysia. This strategic investment of over USD 10 million underscores Intrinseque Health’s ongoing commitment to expanding its global operations and delivering best-in-class clinical supply chain solutions to the clinical trials industry.

The new state-of-the-art facility is being purpose-built to meet the stringent requirements for Good Manufacturing Practice (GMP) storage, offering a secure, controlled, and compliant environment for a wide range of clinical and commercial products. Designed to support the growing demands of pharmaceutical, biotech, and healthcare partners, the warehouse will incorporate advanced technologies, environmental monitoring systems, and scalable capacity to ensure optimal product integrity.

"Establishing this GMP-certified warehouse marks a critical step in our strategic growth plan," said Nitin Jain, President & CEO, Intrinseque Health.

"It not only strengthens our operational capabilities in the Asia-Pacific region but also enhances our ability to deliver reliable, compliant, and efficient clinical supply chain services, such as storage, labeling, printing, and inventory management, to our clients globally," Mr. Jain added.

Strategically situated in Melaka, the new warehouse will provide seamless access to key logistics hubs across Southeast Asia, enabling faster distribution and enhanced service agility. With scalability built into the design, Intrinseque Health has plans for further expansion at the site to accommodate the growing needs of the pharmaceutical, biotech, and healthcare industries.

The addition of this warehouse aligns with the increasing global demand for specialized GMP storage solutions, driven by the rise of complex biologics, personalized medicine, and expanding clinical research activities. Intrinseque Health’s new facility stands ready to support these evolving market requirements with world-class infrastructure and a steadfast focus on quality.

About Intrinseque Health

Intrinseque Health is an EN ISO 13485, ISO 9001 & GDPMDS certified global clinical development support organisation, accomplished in facilitating the development of clinical trial studies globally. Intrinseque Health has expanded its presence worldwide with offices present in countries including the United States (Delaware), The Netherlands (Amsterdam), United Kingdom (London), China (Beijing), Taiwan (Taipei), South Korea (Seoul), India (Delhi), Malaysia and Singapore. Being managed by drug development professionals with over 300 years of combined experience supporting global clinical trials across various therapeutic areas, the team at Intrinseque knows and understands the needs of the clients while providing best-in-class, comprehensive and robust solutions to overcome the hurdles and pain points of conducting a clinical trial.

Intrinseque Health is the industry expert in solving clinical supply chain challenges, such as product availability & lead times, selection of in-country sourcing Vs. import, import regulations and IOR/EOR requirements, storage & warehousing, kitting, labelling & printing, installation, calibration, validation, servicing & maintenance of equipment and supplies, local sourcing, and procurement services, all while maintaining the highest levels of quality throughout study timelines. Intrinseque Health engages early with its clients and utilises an operational methodology based on a proven, cost-effective clinical supply chain strategy for each clinical trial. It firmly believes that even the most minor and essential items, irrespective of their utility, should be available at sites at all times, because nothing is more important than the value of a patient’s life. Intrinseque Health aims to become the global leader in clinical trial support services and constantly thrives in innovating and offering unique solutions.

Prajjwal Sharma
Intrinseque Health
+65 9101 9015
[email protected]
Visit us on social media:
LinkedIn
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next